ZSWIM7 Inhibitors
ZSWIM7 (Zinc Finger SWIM-Type Containing 7) is an intriguing protein implicated in various cellular functions related to DNA repair and gene expression regulation. The SWIM-type zinc finger domain that characterizes ZSWIM7 suggests a role in mediating protein-protein interactions, which are essential for its involvement in chromatin remodeling and maintenance of genomic stability. This protein is thought to interact with other components of the DNA repair machinery, facilitating the correction of DNA damage and thereby contributing to the cell's ability to maintain genetic integrity. Additionally, ZSWIM7 has been associated with the regulation of transcription by influencing the accessibility of transcription factors to their DNA binding sites, playing a critical role in the control of gene expression and impacting cellular processes such as cell cycle progression and differentiation.
The inhibition of ZSWIM7 can occur through various biological mechanisms that directly or indirectly affect its function and activity within the cell. One common method of inhibiting ZSWIM7 involves the downregulation of its expression at the transcriptional level, which can be mediated by transcriptional repressors or through epigenetic modifications such as DNA methylation and histone modification. These changes can reduce the availability of ZSWIM7 mRNA, consequently decreasing protein synthesis and limiting its functional presence in DNA repair and gene regulation pathways. Another significant mechanism of inhibition includes post-translational modifications that alter the protein's stability, localization, or its ability to interact with other proteins. For example, ubiquitination can target ZSWIM7 for proteasomal degradation, effectively reducing its influence on DNA repair processes. Additionally, modifications such as phosphorylation or acetylation could impact the ability of ZSWIM7 to bind to other proteins or DNA, thereby modulating its role in transcription regulation and chromatin remodeling. These regulatory mechanisms ensure that ZSWIM7 activity is finely controlled, allowing the cell to adapt to various metabolic needs or stress conditions effectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound inhibits p38 MAP kinase, a key component in stress signaling. If ZSWIM7 is involved in stress-related pathways, the inhibition of p38 can alter ZSWIM7’s influence on downstream gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine can demethylate genomic regions, thereby affecting the transcriptional status of genes. If ZSWIM7 participates in DNA methylation-dependent transcriptional control, this compound can disturb such regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This JNK inhibitor can block stress-activated signaling pathways. If ZSWIM7 is implicated in cellular stress response via the JNK pathway, then SP600125 will significantly inhibit its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD98059 blocks the activation of MAPK/ERK, disrupting this signaling cascade. Should ZSWIM7 function as a downstream effector in this pathway, its role would be substantially reduced. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
This compound is a non-selective kinase inhibitor that can interfere with a plethora of cellular signaling pathways. If ZSWIM7 serves as an adapter protein in any kinase-related processes, Staurosporine can abrogate its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor can block Akt phosphorylation. If ZSWIM7's function is contingent on the PI3K-Akt pathway, LY294002 can inhibit this interaction, rendering ZSWIM7 ineffective. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
This compound interferes with the MDM2-p53 interaction. If ZSWIM7 is involved in p53 stabilization or degradation, Nutlin-3 can significantly affect its function by altering p53 levels. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
This inhibitor targets cyclin-dependent kinases, directly influencing the cell cycle. If ZSWIM7 has a role in cell cycle regulation, its function will be inhibited by Alsterpaullone. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, this compound can halt cellular growth and autophagy processes. If ZSWIM7 has a regulatory role in these processes, Rapamycin can impede its function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
This compound destabilizes microtubules. Should ZSWIM7 be involved in cellular transport or structure, Nocodazole would effectively inhibit these functions. | ||||||